Pascal Sturmfels

Pascal Sturmfels is a research scientist focused on the intersection of deep learning and structural biology, particularly in drug discovery applications. They completed their PhD in 2024 at the University of Washington, where their research concentrated on interpretable machine learning methods. Previously, Pascal held various research and engineering roles, including positions at UC Berkeley, Microsoft, and Meta, where they contributed to significant advancements in computational biology and machine learning. Currently, Pascal works as a Deep Learning Scientist at Vilya Therapeutics.